Literature DB >> 17502553

Predictors of diagnosis in Huntington disease.

Douglas R Langbehn1, Jane S Paulsen.   

Abstract

OBJECTIVE: Subtle signs and symptoms of Huntington disease (HD) are often present before impairments reach a point where the neurologic disease is manifest and a diagnosis must be considered. The objective is to examine the prognostic significance of these early clinical signs and symptoms regarding time until unequivocal clinical HD diagnosis.
METHODS: We analyzed longitudinal data from 218 at-risk but healthy participants in the Huntington Study Group database who had either normal motor examination results or minimal soft motor signs at first observation. This group was followed periodically in HD clinics for up to 4.5 years. We used survival analysis to examine predictors of time until HD diagnosis.
RESULTS: Diagnostic prediction was significantly improved using specific, nonredundant items from the Unified Huntington's Disease Rating Scale. When a movement disorder specialist initially had a global impression of "soft signs" present, cumulative relative risk of diagnosis was 4.68 times greater at 1.5 years of follow-up and 3.58 at 3 years. A neuropsychological test pattern with psychomotor speed 1 SD worse than a semantic knowledge measure increased cumulative risk by 1.99 times at 1.5 years and 1.81 at 3 years. Finally, reports of various subjective HD symptoms increased 3-year relative risk by 2.6 to 3.4.
CONCLUSIONS: Findings demonstrate that neuropsychological performance and both the clinician rating and the patient subjective perception of motor difficulties contribute nonredundantly to a prediction of Huntington disease diagnosis. These findings may have implications for prognostic assessment of persons at risk and eventually assist with early interventions.

Entities:  

Mesh:

Year:  2007        PMID: 17502553     DOI: 10.1212/01.wnl.0000261918.90053.96

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

1.  Challenges assessing clinical endpoints in early Huntington disease.

Authors:  Jane S Paulsen; Chiachi Wang; Kevin Duff; Roger Barker; Martha Nance; Leigh Beglinger; David Moser; Janet K Williams; Sheila Simpson; Douglas Langbehn; Daniel P van Kammen
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

2.  Nonparametric modeling and analysis of association between Huntington's disease onset and CAG repeats.

Authors:  Yanyuan Ma; Yuanjia Wang
Journal:  Stat Med       Date:  2013-09-12       Impact factor: 2.373

3.  Language deficits in pre-symptomatic Huntington's disease: evidence from Hungarian.

Authors:  Dezso Nemeth; Cristina D Dye; Tamás Sefcsik; Karolina Janacsek; Zsolt Turi; Zsuzsa Londe; Péter Klivenyi; Zsigmond Tamás Kincses; Nikoletta Szabó; László Vecsei; Michael T Ullman
Journal:  Brain Lang       Date:  2012-04-24       Impact factor: 2.381

4.  Early Detection of Huntington Disease.

Authors:  Jane S Paulsen
Journal:  Future Neurol       Date:  2010-01

5.  Earliest functional declines in Huntington disease.

Authors:  Leigh J Beglinger; Justin J F O'Rourke; Chiachi Wang; Douglas R Langbehn; Kevin Duff; Jane S Paulsen
Journal:  Psychiatry Res       Date:  2010-05-15       Impact factor: 3.222

Review 6.  CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches.

Authors:  Douglas R Langbehn; Michael R Hayden; Jane S Paulsen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-03-05       Impact factor: 3.568

7.  Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.

Authors:  Jane S Paulsen; Jeffrey D Long; Christopher A Ross; Deborah L Harrington; Cheryl J Erwin; Janet K Williams; Holly James Westervelt; Hans J Johnson; Elizabeth H Aylward; Ying Zhang; H Jeremy Bockholt; Roger A Barker
Journal:  Lancet Neurol       Date:  2014-11-03       Impact factor: 44.182

Review 8.  Cognitive impairment in Huntington disease: diagnosis and treatment.

Authors:  Jane S Paulsen
Journal:  Curr Neurol Neurosci Rep       Date:  2011-10       Impact factor: 5.081

9.  Indexing disease progression at study entry with individuals at-risk for Huntington disease.

Authors:  Ying Zhang; Jeffrey D Long; James A Mills; John H Warner; Wenjing Lu; Jane S Paulsen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-08-19       Impact factor: 3.568

10.  Cognitive change in patients with Huntington disease on the Repeatable Battery for the Assessment of Neuropsychological Status.

Authors:  Leigh J Beglinger; Kevin Duff; Jessica Allison; Danielle Theriault; Justin J F O'Rourke; Anne Leserman; Jane S Paulsen
Journal:  J Clin Exp Neuropsychol       Date:  2009-10-29       Impact factor: 2.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.